CIK 0001787400
- Non-accelerated filer
- Smaller reporting company
Nkarta, Inc.
Sign in to watch- Ticker
- NKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474515206
- Phone
- +1 925-407-1049
- Business address
- 1150 VETERANS BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-03 | Trager James Chief Scientific Officer | Exercise or conversion · Stock Option (right to buy) | −2,250 | 57,662 | ||
| 2021-04-01 | RA CAPITAL MANAGEMENT, L.P. Director | Other acquisition | +260,819 | $32.90 | $8.6M | 260,819 |
| 2021-04-01 | RA CAPITAL MANAGEMENT, L.P. Director | Other acquisition | +307,214 | $32.90 | $10.1M | 4,589,999 |
| 2021-04-01 | Mahmood Nadir | Exercise or conversion | +3,500 | $3.89 | $14K | 34,988 |
| 2021-04-01 | Mahmood Nadir | Sale | −3,500 | $32.70 | $114K | 31,488 |
| 2021-04-01 | Mahmood Nadir | Exercise or conversion · Stock Option (right to buy) | −3,500 | 74,243 | ||
| 2021-03-30 | HASTINGS PAUL J Chief Executive Officer | Sale | −11,461 | $30.23 | $346K | 241,600 |
| 2021-03-30 | HASTINGS PAUL J Chief Executive Officer | Sale | −2,409 | $31.24 | $75K | 239,191 |
| 2021-03-30 | HASTINGS PAUL J Chief Executive Officer | Sale | −3,130 | $32.21 | $101K | 236,061 |
| 2021-02-02 | Trager James Chief Scientific Officer | Exercise or conversion | +2,800 | $18.00 | $50K | 49,872 |
| 2021-02-02 | Trager James Chief Scientific Officer | Sale | −2,800 | $40.00 | $112K | 47,072 |
| 2021-02-02 | Trager James Chief Scientific Officer | Exercise or conversion · Stock Option (right to buy) | −2,800 | 79,600 | ||
| 2021-02-01 | Trager James Chief Scientific Officer | Exercise or conversion | +2,250 | $3.89 | $9K | 50,672 |
| 2021-02-01 | Trager James Chief Scientific Officer | Sale | −2,034 | $38.07 | $77K | 48,638 |
| 2021-02-01 | Trager James Chief Scientific Officer | Sale | −1,566 | $39.46 | $62K | 47,072 |
| 2021-02-01 | Trager James Chief Scientific Officer | Exercise or conversion · Stock Option (right to buy) | −2,250 | 59,912 | ||
| 2021-01-25 | Mahmood Nadir | Exercise or conversion | +5,500 | $3.89 | $21K | 36,988 |
| 2021-01-25 | Mahmood Nadir | Sale | −2,000 | $48.86 | $98K | 34,988 |
| 2021-01-25 | Mahmood Nadir | Sale | −3,500 | $48.40 | $169K | 31,488 |
| 2021-01-25 | Mahmood Nadir | Exercise or conversion · Stock Option (right to buy) | −5,500 | 77,743 |
Page 14 of 19 · 364 trades